 | • レポートコード：B-MOR-08501 • 出版社/出版日：Mordor Intelligence / 2018年5月1日 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（受注後2営業日） • 産業分類：医療・製薬 |
| Single User（1名様用） | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User（7名様用） | ￥666,000 (USD4,500) | ▷ お問い合わせ |
| Corporate User | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、呼吸器モニターの世界市場について調べ、呼吸器モニターの世界規模、市場動向、市場環境、装置の種類別（肺活量計、ピークフローメーター、スリープテスト装置、ガス分析計、パルスオキシメーター、カプノグラフ、その他）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。 ・イントロダクション ・エグゼクティブサマリー ・呼吸器モニターの世界市場インサイト ・呼吸器モニターの世界市場環境 ・呼吸器モニターの世界市場動向 ・呼吸器モニターの世界市場規模 ・呼吸器モニターの世界市場規模：装置の種類別（肺活量計、ピークフローメーター、スリープテスト装置、ガス分析計、パルスオキシメーター、カプノグラフ、その他） ・呼吸器モニターの世界市場：地域別市場規模・分析 ・呼吸器モニターの北米市場規模・予測 ・呼吸器モニターのアメリカ市場規模・予測 ・呼吸器モニターのヨーロッパ市場規模・予測 ・呼吸器モニターのアジア市場規模・予測 ・呼吸器モニターの日本市場規模・予測 ・呼吸器モニターの中国市場規模・予測 ・呼吸器モニターのインド市場規模・予測 ・呼吸器モニターの韓国市場規模・予測 ・関連企業情報・競争状況 |
The respiratory monitoring market is expected to witness a CAGR of 9.5%, during the forecast period. North America has been accounted for the largest share in the global market in 2017 and it is expected to grow at the considerable rate in the upcoming future.
Rising Prevalence of Respiratory Diseases
The respiratory diseases, such as asthma, lung cancer, COPDs, are increasing at an alarming rate in both the developed and developing countries, which is driving the respiratory monitoring market globally. Based on the data from Centers for Disease Control and Prevention (CDC), around 25 million Americans have been found affected by asthma, in that 7.6 percent are adults and 8.4 percent are children. In 2015, 47.5 percent of children, aged 18 and younger, who had asthma reported having one or more asthma attacks in the past year. Due to this, continuously increasing respiratory diseases is creating a demand for the early diagnosis of these diseases, which results in more usage of the respiratory devices. Hence, due to the rising prevalence of the respiratory diseases the market is likely to grow.
The other factors include the rapid growth in geriatric population, urbanization, and growing pollution levels, high prevalence of tobacco smoking and development of advanced technologies.
High Price of the Monitoring Devices
The average cost of the respiratory medical devices is generally between USD 2000- 5000. Due to the high cost, the low-income countries cannot afford these respiratory equipment’s. Hence, the cost of acquiring the respiratory medical devices is very high, considering the fact that a single device is not sufficient per hospital. The maintenance costs and service contracts are also very high for these devices. Therefore, due to this increasing price the mass adoption is being restricted, which is likely to impede the growth of this market. The other factor also includes the reimbursement concerns.
North America Dominates the Market
North America dominates the global respiratory monitoring market due to the high medical reimburstments facilities, and the increasing technological advancements. Asia Pacific is also, projected to have the fastest growth owing to the rapidly increasing aging population, rise in the consumer awareness and the growing of the medical tourism in the developing nations, such as China and India in this region.
Key Developments in the Market
• April 2017 – ResMed launched AirMini, the world’s smallest CPAP machine for the treatment of sleep apnea
Major Players- COVIDIEN, GE HEALTHCARE, PHILIPS HEALTHCARE, SIEMENS HEALTHCARE, RESMED, MERCK & CO. INC., DRAEGERWERK, CALONDO PHARMACEUTICALS INC. AND QUARK PHARMACEUTICALS INC., amongst others.
Reasons to Purchase this Report
• Current and future respiratory monitoring market outlook in the developed and emerging markets
• Analyzing various perspectives of the market with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness fastest growth during the forecast period
• Identifying the latest developments, market shares, and strategies employed by the major market players
• 3 months analyst support, along with the Market Estimate sheet (in Excel)
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our analyst, who will ensure you get a report that suits your needs
レポート目次1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter’s Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry Within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Rapid Growth in Geriatric Population
6.1.2 Rising Prevalence of Respiratory Diseases
6.1.3 Urbanization and Growing Pollution Levels
6.1.4 High Prevalence of Tobacco Smoking
6.1.5 Development of Advanced Technologies
6.2 Market Restraints
6.2.1 Reimbursement Concerns
6.2.2 High Price of the Monitoring Devices
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Type of Device
7.1.1 Spirometers
7.1.2 Peak Flow Meters
7.1.3 Sleep Test Devices
7.1.4 Gas Analyzers
7.1.5 Pulse Oximeters
7.1.6 Capnographs
7.1.7 Others
7.2 By Geography
7.2.1 North America
7.2.1.1 United States
7.2.1.2 Canada
7.2.1.3 Mexico
7.2.2 Europe
7.2.2.1 France
7.2.2.2 Germany
7.2.2.3 United Kingdom
7.2.2.4 Italy
7.2.2.5 Spain
7.2.2.6 Rest of Europe
7.2.3 Asia-Pacific
7.2.3.1 China
7.2.3.2 Japan
7.2.3.3 India
7.2.3.4 Australia & New Zealand
7.2.3.5 South Korea
7.2.3.6 Rest of Asia-Pacific
7.2.4 Middle East & Africa
7.2.4.1 GCC
7.2.4.2 South Africa
7.2.4.3 Rest of the Middle East & Africa
7.2.5 South America
7.2.5.1 Brazil
7.2.5.2 Argentina
7.2.5.3 Rest of South America
8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 Airsep Corporation
9.2 AstraZeneca PLC
9.3 Covidien
9.4 Draegerwerk
9.5 GE Healthcare
9.6 Hamilton Medical
9.7 Maquet
9.8 Philips Healthcare
9.9 Resmed
9.10 Siemens Healthcare
9.11 List Not Exhaustive
10. Future of the Market